NewslettersHuman Immunology NewsImmune Regulation NewsRice, Baylor Developing ‘Glyco-Immune’ Checkpoint InhibitorBy lbeveridge - May 19, 20230335Researchers from Rice University and Baylor College of Medicine are hoping a first-of-its-kind “glyco-immune” checkpoint inhibitor could be the key to stopping bone cancer metastasis for breast cancer survivors.[Rice University]Press Release